Results 61 to 70 of about 12,597 (249)

Identification of presynaptic neurotoxin complexes in the venoms of three Australian copperheads (Austrelaps spp.) and the efficacy of tiger snake antivenom to prevent or reverse neurotoxicity [PDF]

open access: yes, 2011
The venom of the Australian lowlands copperhead, Austrelaps superbus, produces significant and potentially lethal neurotoxic paralysis in cases of clinical envenomation. However, little is known about the neurotoxic components within this venom or venoms
Marcon, F, Nicholson, GM
core   +1 more source

Correction to: Postmortem histopathology and detection of venom by ELISA following suicide by cobra (Naja kaouthia) envenomation [PDF]

open access: bronze, 2022
Dayanira Paniagua   +5 more
openalex   +1 more source

Polymeric Nanoparticles for the Diagnosis and Treatment of Snakebite

open access: yesMacromolecular Chemistry and Physics, Volume 227, Issue 1, 15 January 2026.
Snakebite envenomation affects between 1.8 and 5.5 million people annually, many of whom suffer disabilities or even death. Current antivenoms are composed of plasma‐derived antibodies. However, there remains an underexplored opportunity to utilise polymer‐based nanoparticles.
Neil Prabhakar   +2 more
wiley   +1 more source

Association Between Fear and Beauty Evaluation of Snakes: Cross-Cultural Findings

open access: yesFrontiers in Psychology, 2018
According to the fear module theory, humans are evolutionarily predisposed to perceive snakes as prioritized stimuli and exhibit a fast emotional and behavioral response toward them.
Eva Landová   +12 more
doaj   +1 more source

Snakebite and its socio-economic impact on the rural population of Tamil Nadu, India [PDF]

open access: yes, 2013
BACKGROUND: Snakebite represents a significant health issue worldwide, affecting several million people each year with as many as 95,000 deaths. India is considered to be the country most affected, but much remains unknown about snakebite incidence in
A Kasturiratne   +30 more
core   +3 more sources

TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults) [PDF]

open access: gold, 2022
Michael Abouyannis   +19 more
openalex   +1 more source

Bioactive Phenolic Compounds from Thapsia garganica L. Different Parts: HPLC‐DAD Profiling,Cholinesterase Inhibition, and Antioxidant Potential

open access: yesChemistrySelect, Volume 11, Issue 1, 8 January 2026.
ABSTRACT This study investigates the biological properties of methanolic and petroleum ether (PE) extracts from the roots and flowers of Thapsia garganica L., providing new insights into its potential medicinal uses. Although T. garganica has a long history in traditional medicine, the anticholinesterase and tyrosinase‐inhibiting activities of this ...
Rania Arabi   +11 more
wiley   +1 more source

Clinical Risk Factors Associated with Poor Outcomes in Snake Envenoming: A Narrative Review

open access: yesToxins, 2023
Snakebite-related fatalities disproportionately affect populations in impoverished socio-economic regions, marked by limited access to adequate healthcare and constrained antivenom availability.
Darryl Wood
doaj   +1 more source

Evaluation of the lethal potency of scorpion and snake venoms and comparison between intraperitoneal and intravenous injection routes. [PDF]

open access: yes, 2014
International audienceScorpion stings and snake bites are major health hazards that lead to suffering of victims and high mortality. Thousands of injuries associated with such stings and bites of venomous animals occur every year worldwide.
Bouhaouala, Balkiss   +6 more
core   +4 more sources

Mortality Benefit of Tranexamic Acid for Hemorrhage With Concurrent Traumatic Brain Injury: Outcomes From a Prospective Cohort Study in a High‐Trauma, Prolonged Care Setting

open access: yesWorld Journal of Surgery, Volume 50, Issue 1, Page 233-243, January 2026.
Early TXA administration (≤ 3 h) in concurrent hemorrhage and TBI was significantly associated with a 22% reduction in mortality at 7 days. TXA treatment was also associated with a significant 29% lower odds of organ failure and non‐significant 11% odds of good neurologic recovery.
Julia M. Dixon   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy